Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 21.3B | 24.4B | 24.4B | 23.4B |
Cost of revenue | 15.8B | 18.2B | 18.2B | 17.2B |
Gross profit | 5.4B | 6.2B | 6.2B | 6.2B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | — | 2.7B | 2.8B | 2.6B |
Operating income | 11.8B | 1.6B | 1.7B | 1.7B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 289.4M | 344.9M | 397.5M | 301.7M |
Other income expense | — | — | — | — |
Pretax income | 865.4M | 1.5B | 1.5B | 1.7B |
Tax provision | 204.4M | 414M | 541.1M | 344.8M |
Net income | 661M | 1.1B | 957.9M | 1.3B |
Basic EPS | — | 5.8 | 5.8 | 7.0 |
Diluted EPS | — | 5.8 | 5.8 | 7.0 |
Basic average shares | — | 192.2M | 192.3M | 192.2M |
Diluted average shares | — | 192.2M | 192.3M | 192.2M |
EBITDA | 1.7B | 2.4B | 2.5B | 2.5B |
Net income from continuing op. | — | — | — | — |
Minority interests | 46.8M | 16.4M | 165.1M | 35.2M |
Preferred stock dividends | 0 | 0 | 0 | 0 |